Cargando…

Formulation and in vitro Evaluation of Alfuzosin Extended Release Tablets Using Directly Compressible Eudragit

The aim of the present study was the determination of formulation factors and the in vitro evaluation of an extended release dosage form of a freely soluble weakly basic drug (alfuzosin hydrochloride). Binary mixer of one hydrophilic polymer (hydroxypropylmethylcellulose) and one directly compressib...

Descripción completa

Detalles Bibliográficos
Autores principales: Roni, M. A., Kibria, G., Jalil, R.
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2865782/
https://www.ncbi.nlm.nih.gov/pubmed/20490290
http://dx.doi.org/10.4103/0250-474X.56019
_version_ 1782180869961678848
author Roni, M. A.
Kibria, G.
Jalil, R.
author_facet Roni, M. A.
Kibria, G.
Jalil, R.
author_sort Roni, M. A.
collection PubMed
description The aim of the present study was the determination of formulation factors and the in vitro evaluation of an extended release dosage form of a freely soluble weakly basic drug (alfuzosin hydrochloride). Binary mixer of one hydrophilic polymer (hydroxypropylmethylcellulose) and one directly compressible Eudragit (RS PO) was used in tablets prepared by direct compression. The amounts of both polymers were taken as independent variables for the 3(2) Factorial design. The percent drug releases at 1, 6, 12 and 20 h were selected as responses. The main effect and interaction terms were quantitatively evaluated using mathematical model. Dissolution data were fitted to zero order, first order, and Higuchi's release kinetics to evaluate kinetic data. Both the diffusion and erosion mechanisms were responsible for drug release as shown by the power law. The release of Alfuzosin was prolonged for 20 h by binary mixer indicating the usefulness of the formulations for once daily dosage forms.
format Text
id pubmed-2865782
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-28657822010-05-20 Formulation and in vitro Evaluation of Alfuzosin Extended Release Tablets Using Directly Compressible Eudragit Roni, M. A. Kibria, G. Jalil, R. Indian J Pharm Sci Research Paper The aim of the present study was the determination of formulation factors and the in vitro evaluation of an extended release dosage form of a freely soluble weakly basic drug (alfuzosin hydrochloride). Binary mixer of one hydrophilic polymer (hydroxypropylmethylcellulose) and one directly compressible Eudragit (RS PO) was used in tablets prepared by direct compression. The amounts of both polymers were taken as independent variables for the 3(2) Factorial design. The percent drug releases at 1, 6, 12 and 20 h were selected as responses. The main effect and interaction terms were quantitatively evaluated using mathematical model. Dissolution data were fitted to zero order, first order, and Higuchi's release kinetics to evaluate kinetic data. Both the diffusion and erosion mechanisms were responsible for drug release as shown by the power law. The release of Alfuzosin was prolonged for 20 h by binary mixer indicating the usefulness of the formulations for once daily dosage forms. Medknow Publications 2009 /pmc/articles/PMC2865782/ /pubmed/20490290 http://dx.doi.org/10.4103/0250-474X.56019 Text en © Indian Journal of Pharmaceutical Sciences http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Paper
Roni, M. A.
Kibria, G.
Jalil, R.
Formulation and in vitro Evaluation of Alfuzosin Extended Release Tablets Using Directly Compressible Eudragit
title Formulation and in vitro Evaluation of Alfuzosin Extended Release Tablets Using Directly Compressible Eudragit
title_full Formulation and in vitro Evaluation of Alfuzosin Extended Release Tablets Using Directly Compressible Eudragit
title_fullStr Formulation and in vitro Evaluation of Alfuzosin Extended Release Tablets Using Directly Compressible Eudragit
title_full_unstemmed Formulation and in vitro Evaluation of Alfuzosin Extended Release Tablets Using Directly Compressible Eudragit
title_short Formulation and in vitro Evaluation of Alfuzosin Extended Release Tablets Using Directly Compressible Eudragit
title_sort formulation and in vitro evaluation of alfuzosin extended release tablets using directly compressible eudragit
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2865782/
https://www.ncbi.nlm.nih.gov/pubmed/20490290
http://dx.doi.org/10.4103/0250-474X.56019
work_keys_str_mv AT ronima formulationandinvitroevaluationofalfuzosinextendedreleasetabletsusingdirectlycompressibleeudragit
AT kibriag formulationandinvitroevaluationofalfuzosinextendedreleasetabletsusingdirectlycompressibleeudragit
AT jalilr formulationandinvitroevaluationofalfuzosinextendedreleasetabletsusingdirectlycompressibleeudragit